Suzhou Ribo Life Science Co., Ltd.

Research Suzhou Ribo Life Science Co., Ltd. (6938.HK) on Bullrun: market cap HKD 8.58B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker6938.HK
ExchangeHK
CountryChina
SectorHealthcare
IndustryBiotechnology
CurrencyHKD
Market capHKD 8.58B
Financial periodFY2025
RevenueCNY 148.51M
Revenue growth4.1%
Net income-CNY 278.06M
Free cash flow-CNY 290.58M
Gross margin90.9%

Valuation Snapshot

latest market cap is HKD 8.58B.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	CNY 148.51M	-CNY 278.06M	-CNY 290.58M	90.9%	n/a	CNY 406.75M	CNY 550.07M	-CNY 93.94M
FY2024	CNY 142.63M	-CNY 270.15M	-CNY 84.09M	91.7%	-1.67	CNY 168.62M	CNY 428.88M	-CNY 110.36M
FY2023	CNY 44.00K	-CNY 428.35M	-CNY 328.18M	45.5%	-2.65	CNY 212.35M	CNY 414.74M	CNY 105.10M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	HKD 8.58B	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 HKD.

About Suzhou Ribo Life Science Co., Ltd.

Suzhou Ribo Life Science Co., Ltd. researches and develops novel therapeutics for the treatment of cardiovascular, metabolic, renal, and liver diseases in Chinese mainland and internationally. It develops RBD4059, which is phase 2 clinical trial for treating thrombotic diseases; RBD5044 that is in phase 2 clinical trial for treating hypertrigly ceridemia; RBD7022, which is in phase 2 clinical trial for the treatment of hypercho lesterolemia;

Related stock research

China stocks China Healthcare stocks A-Z stock index

Other Healthcare stocks

Hualan Biological Engineering INC (002007.SZ) Shanghai RAAS Blood Products Co Ltd (002252.SZ) Asymchem Laboratories (Tianjin) Co., Ltd. (002821.SZ) Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) CANbridge Pharmaceuticals Inc. (1228.HK) 3D Medicines Inc. (1244.HK) Ocumension Therapeutics (1477.HK) 3SBio Inc. (1530.HK) LongBio Pharma (Suzhou) Co., Ltd. (1779.HK) Innovent Biologics, Inc. (1801.HK) Viva Biotech Holdings (1873.HK) BioDlink International Company Limited (1875.HK)

Frequently asked questions

What is Suzhou Ribo Life Science Co., Ltd.'s market cap?

Suzhou Ribo Life Science Co., Ltd.'s market capitalization is HKD 8.58B.

What does Suzhou Ribo Life Science Co., Ltd. do?

Suzhou Ribo Life Science Co., Ltd. researches and develops novel therapeutics for the treatment of cardiovascular, metabolic, renal, and liver diseases in Chinese mainland and internationally.